Why is Brooks Lab. falling/rising?

As of 11-Jul, Brooks Laboratories Ltd is experiencing a price increase, currently at Rs 148.05, reflecting a rise of 2.9 (2.0%). The stock has shown strong performance recently, gaining 6.05% over the last three days and outperforming its sector by 1.42% today. It opened with a 2% gain and reached an intraday high of Rs 148.05. Additionally, the stock has demonstrated impressive returns over various periods, including a 70.17% increase over the past year, significantly outpacing the broader market's return of 3.26%. However, there has been a notable decline in investor participation, with delivery volume dropping by 99.83% compared to the five-day average, which may raise concerns about sustainability.
In the broader market context, Brooks Laboratories Ltd has outperformed the Sensex in the short term, with a 1-week return of 7.67% compared to the benchmark's decline of 1.12%. This strong short-term performance is bolstered by increasing participation from institutional investors, who have raised their stake in the company by 0.53%, indicating confidence in its potential. However, the company faces challenges with weak long-term fundamentals, including an average Return on Equity (ROE) of 0% and a declining net sales growth rate. These factors suggest that while the stock is currently rising, there are underlying issues that could impact its long-term viability.